| Time | Topics | Speaker/s |
|
14:30
-
14:35
|
Intravitreal Bevacizumab Alone or Combined with 1mg Triamcinolone in Diabetic Macular Edema. a Randomized Clinical Trial
|
Mohammad Riazi, MD
|
|
14:37
-
14:42
|
Evaluation of Combined Association of MCP-2518 and C3 Polymorphisms with Age-Related Macular Degeneration
|
Mohammadhossein Jabbarpourbonyadi, MD
|
|
14:44
-
14:49
|
Evaluation of C-Reactive Protein and CC-Cytokine Ligand 2 Polymorphism Interaction for Age-Related Macular Degeneration
|
Mohammadhossein Jabbarpourbonyadi, MD
|
|
14:51
-
14:56
|
Preparation, Characterization, and in Vivo Evaluation of Solid Lipid Nanoparticles Containing Diclofenac after Intravitreal Administration
|
Mojtaba Abrishami, MD
|
|
14:58
-
15:03
|
Efficiency and Effectiveness of Polymeric Micellar Nanocarriers form of Dexamethasone on Ocular Inflammation in a Rabbit Animal Model
|
Mostafa Feghhi, MD
|
|
15:05
-
15:10
|
Post Operative Inflammation after Phakic Iol Implantation
|
Ali Tabatabaei, MD
|
|
15:12
-
15:17
|
Efficient Integration of Isolated Cone Photoreceptor Precursors from a Novel Cone-GFP Reporter Mouse Line, Into Rodent Retina
|
Narsis Daftarian, MD
|
|
15:19
-
15:24
|
Correlation of Central Choroidal Thickness and Central Macular Thickness Changes after Treatment of Diabetic Macular Edema.
|
Ramin Nourinia, MD
|
|
15:26
-
15:31
|
Fibrovascular Tissue Formation after Intravitreal Injection of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Patients with Retinitis Pigmentosa: Clinical Trial Phase I, Safety
|
Ramin Nourinia, MD
|
|
15:33
-
15:38
|
Clinical Practice Guidelines for the Management of Diabetic Retinopathy; Customized for Iranian Population
|
Sareh Safi,
|
|
15:40
-
15:45
|
Pseudomonas Aeruginosa Endophthalmitis; Clinical Outcomes and Antibiotic Susceptibilities
|
Sayyed amirpooya Alemzadeh, MD
|
|
15:47
-
15:52
|
Studying Probable Toxic Effect of Melatonin on Human Retina Using Electroretinographical Technique
|
Yasaman Farabi,
|